This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2011 Oct 14;10(11):802-3.

doi: 10.1038/nrd3594.

Regulatory watch: leading hedgehog inhibitor submitted for approval as skin cancer drug

No authors listed

PMID: 21997751
DOI: 10.1038/nrd3594

Regulatory watch: leading hedgehog inhibitor submitted for approval as skin cancer drug

No authors listed. Nat Rev Drug Discov. 2011.

. 2011 Oct 14;10(11):802-3.

doi: 10.1038/nrd3594.

PMID: 21997751
DOI: 10.1038/nrd3594

No abstract available

PubMed Disclaimer

Similar articles

Hedgehog inhibitor gets landmark skin cancer approval, but questions remain for wider potential.
Guha M. Guha M. Nat Rev Drug Discov. 2012 Mar 30;11(4):257-8. doi: 10.1038/nrd3714. Nat Rev Drug Discov. 2012. PMID: 22460111 No abstract available.
Vismodegib (Erivedge) for basal cell carcinoma.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2012 Jul 9;54(1394):53-4. Med Lett Drugs Ther. 2012. PMID: 22777303 No abstract available.
Hedgehog hopes lifted by approval... and stung by failure.
Allison M. Allison M. Nat Biotechnol. 2012 Mar 7;30(3):203. doi: 10.1038/nbt0312-203. Nat Biotechnol. 2012. PMID: 22398601 No abstract available.
Vismodegib: a hedgehog pathway inhibitor for locally advanced and metastatic basal cell carcinomas.
Sobanko JF, Okman J, Miller C. Sobanko JF, et al. J Drugs Dermatol. 2013 Oct;12(10 Suppl):s154-5. J Drugs Dermatol. 2013. PMID: 24085062 Review.
Vismodegib and the hedgehog pathway: a new treatment for basal cell carcinoma.
Cirrone F, Harris CS. Cirrone F, et al. Clin Ther. 2012 Oct;34(10):2039-50. doi: 10.1016/j.clinthera.2012.08.011. Epub 2012 Oct 1. Clin Ther. 2012. PMID: 23036338 Review.

See all similar articles

Cited by

Diagnosing the decline in pharmaceutical R&D efficiency.
Scannell JW, Blanckley A, Boldon H, Warrington B. Scannell JW, et al. Nat Rev Drug Discov. 2012 Mar 1;11(3):191-200. doi: 10.1038/nrd3681. Nat Rev Drug Discov. 2012. PMID: 22378269 Review.

References

1. Science. 1998 Jun 5;280(5369):1603-7 - PubMed
1. Nature. 2000 Aug 31;406(6799):1005-9 - PubMed
1. Genes Dev. 2002 Nov 1;16(21):2743-8 - PubMed
1. Nat Rev Drug Discov. 2006 Dec;5(12):1026-33 - PubMed
1. Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14071-6 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information